198 related articles for article (PubMed ID: 12790781)
1. Oestrogens and prostate cancer.
Risbridger GP; Bianco JJ; Ellem SJ; McPherson SJ
Endocr Relat Cancer; 2003 Jun; 10(2):187-91. PubMed ID: 12790781
[TBL] [Abstract][Full Text] [Related]
2. Elevated androgens and prolactin in aromatase-deficient mice cause enlargement, but not malignancy, of the prostate gland.
McPherson SJ; Wang H; Jones ME; Pedersen J; Iismaa TP; Wreford N; Simpson ER; Risbridger GP
Endocrinology; 2001 Jun; 142(6):2458-67. PubMed ID: 11356695
[TBL] [Abstract][Full Text] [Related]
3. Aromatase and prostate cancer.
Ellem SJ; Risbridger GP
Minerva Endocrinol; 2006 Mar; 31(1):1-12. PubMed ID: 16498360
[TBL] [Abstract][Full Text] [Related]
4. Oestrogen and benign prostatic hyperplasia: effects on stromal cell proliferation and local formation from androgen.
Ho CK; Nanda J; Chapman KE; Habib FK
J Endocrinol; 2008 Jun; 197(3):483-91. PubMed ID: 18492814
[TBL] [Abstract][Full Text] [Related]
5. Essential role for estrogen receptor beta in stromal-epithelial regulation of prostatic hyperplasia.
McPherson SJ; Ellem SJ; Simpson ER; Patchev V; Fritzemeier KH; Risbridger GP
Endocrinology; 2007 Feb; 148(2):566-74. PubMed ID: 17068134
[TBL] [Abstract][Full Text] [Related]
6. Aromatase up-regulation, insulin and raised intracellular oestrogens in men, induce adiposity, metabolic syndrome and prostate disease, via aberrant ER-α and GPER signalling.
Williams G
Mol Cell Endocrinol; 2012 Apr; 351(2):269-78. PubMed ID: 22233684
[TBL] [Abstract][Full Text] [Related]
7. Anti-androgenic action by red clover-derived dietary isoflavones reduces non-malignant prostate enlargement in aromatase knockout (ArKo) mice.
Jarred RA; McPherson SJ; Jones ME; Simpson ER; Risbridger GP
Prostate; 2003 Jun; 56(1):54-64. PubMed ID: 12746847
[TBL] [Abstract][Full Text] [Related]
8. Aromatase and regulating the estrogen:androgen ratio in the prostate gland.
Ellem SJ; Risbridger GP
J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):246-51. PubMed ID: 19896534
[TBL] [Abstract][Full Text] [Related]
9. The role of Eralpha and ERbeta in the prostate: insights from genetic models and isoform-selective ligands.
McPherson SJ; Ellem SJ; Patchev V; Fritzemeier KH; Risbridger GP
Ernst Schering Found Symp Proc; 2006; (1):131-47. PubMed ID: 17824175
[TBL] [Abstract][Full Text] [Related]
10. In touch with your feminine side: how oestrogen metabolism impacts prostate cancer.
Rahman HP; Hofland J; Foster PA
Endocr Relat Cancer; 2016 Jun; 23(6):R249-66. PubMed ID: 27194038
[TBL] [Abstract][Full Text] [Related]
11. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
Carruba G
J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
[TBL] [Abstract][Full Text] [Related]
12. Transient neonatal estrogen exposure to estrogen-deficient mice (aromatase knockout) reduces prostate weight and induces inflammation in late life.
Bianco JJ; McPherson SJ; Wang H; Prins GS; Risbridger GP
Am J Pathol; 2006 Jun; 168(6):1869-78. PubMed ID: 16723702
[TBL] [Abstract][Full Text] [Related]
13. Androgenic to oestrogenic switch in the human adult prostate gland is regulated by epigenetic silencing of steroid 5α-reductase 2.
Wang Z; Hu L; Salari K; Bechis SK; Ge R; Wu S; Rassoulian C; Pham J; Wu CL; Tabatabaei S; Strand DW; Olumi AF
J Pathol; 2017 Dec; 243(4):457-467. PubMed ID: 28940538
[TBL] [Abstract][Full Text] [Related]
14. Impact of constitutional genetic variation in androgen/oestrogen-regulating genes on age-related changes in human prostate.
Azzouzi AR; Cochand-Priollet B; Mangin P; Fournier G; Berthon P; Latil A; Cussenot O
Eur J Endocrinol; 2002 Oct; 147(4):479-84. PubMed ID: 12370109
[TBL] [Abstract][Full Text] [Related]
15. The ovarian phenotype of the aromatase knockout (ArKO) mouse.
Britt KL; Drummond AE; Dyson M; Wreford NG; Jones ME; Simpson ER; Findlay JK
J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):181-5. PubMed ID: 11850223
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of neurosteroidal oestrogen using gene-disrupted and transgenic mice.
Harada N; Wakatsuki T; Aste N; Yoshimura N; Honda SI
J Neuroendocrinol; 2009 Mar; 21(4):365-9. PubMed ID: 19226348
[TBL] [Abstract][Full Text] [Related]
17. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.
Bonkhoff H; Remberger K
Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398
[TBL] [Abstract][Full Text] [Related]
18. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
Gao J; Arnold JT; Isaacs JT
Cancer Res; 2001 Jul; 61(13):5038-44. PubMed ID: 11431338
[TBL] [Abstract][Full Text] [Related]
19. Estrogenic effects on prostatic differentiation and carcinogenesis.
Cunha GR; Wang YZ; Hayward SW; Risbridger GP
Reprod Fertil Dev; 2001; 13(4):285-96. PubMed ID: 11800167
[TBL] [Abstract][Full Text] [Related]
20. 5alpha-reductase isozymes and aromatase are differentially expressed and active in the androgen-independent human prostate cancer cell lines DU145 and PC3.
Negri-Cesi P; Colciago A; Poletti A; Motta M
Prostate; 1999 Dec; 41(4):224-32. PubMed ID: 10544295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
